Till Uhlig

Professor

University of Oslo

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Till Uhlig is a Professor at the University of Oslo in Norway. His research primarily focuses on rheumatoid arthritis and gout, with recent publications addressing topics such as immune checkpoint molecules, the risk of serious infections in patients on immunomodulating therapy, and the effects of glucocorticoid treatment. He has also contributed to studies on the long-term adherence to urate-lowering therapy in gout and the correlation of specific immune cell proportions with bone loss in rheumatoid arthritis.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Merete Lund Hetland

Professor

University of Copenhagen

DENMARK

View details

Espen André Haavardsholm

Head of Research and Innovation

NORWAY

View details

Lisa K. Stamp

NEW ZEALAND

View details

Tore Kristian Kvien

Professor

University of Oslo

NORWAY

View details

Anthony Doyle

Associate Professor

University of Auckland

NEW ZEALAND

View details

Lotta Ljung

Karolinska Institutet

SWEDEN

View details

Daniela Di Giuseppe

Karolinska University Hospital

SWEDEN

View details

Mikkel Østergaard

Professor

Rigshospitalet

DENMARK

View details

Fernando Perez-Ruiz

Associate Professor

Universidad del País Vasco Facultad de Farmacia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Till Uhlig

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial

Association of Soluble Immune Checkpoint Molecules PD1 and 4‐1BB With CTLA‐4Ig Treatment Response in Early Rheumatoid Arthritis

Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls: Reply

Remission in gout is possible: 5-year follow-up in the NOR-Gout study

Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study

Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis

Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries

Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study

Remission Is the Mission in Gout

Changes in Tophus Composition During Urate‐Lowering Therapy: A Dual‐Energy Computed Tomography Study

Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study

Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study

Utility of dimethylsulfoxide to preserve synovial fluid samples for microcrystal detection and identification

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Associations between joint pathologies and central sensitization in persons with hand osteoarthritis: results from the Nor-Hand study

Collaborators (9)

Merete Lund Hetland

Espen André Haavardsholm

Lisa K. Stamp

Tore Kristian Kvien

Anthony Doyle

Lotta Ljung

Daniela Di Giuseppe

Mikkel Østergaard

Fernando Perez-Ruiz

Make your next move.